Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2003

View Archived Issues

New p38 inhibitors with utility in COPD

AstraZeneca describes new immunosuppressants with potential in respiratory disorders

Bayer scientists present novel bradykinin B1 antagonists for use as analgesic agents

Dopamine D2 receptor partial agonists prepared and tested at Wyeth

New modulators of vasopressin and/or oxytocin receptors covered by Sanofi-Synthelabo patent

Series of melanocortin MC4 receptor agonists in early development at Merck

Dr. Reddy's describes novel antidiabetic agents

New MRI agents designed at Bracco

NicOx reports substantial progress for 2002

New data on adefovir dipivoxil in the long-term treatment of chronic hepatitis B

Aphton presents phase III results for G17DT to foreign regulatory authority

Cardiome reviews 2002, presents outlook for 2003

Mechanisms underlying effects of zoledronic acid on prostate cancer bone metastases

AVAC for atopic dermatitis completes phase I testing in children

Ranexa NDA accepted for filing

NIAID to fund GTC clinical production of MSP-1 malaria vaccine

Oral tazarotene completes phase III studies

MVA-BN nef shows promise in HIV trial

Pennsaid approved in Italy

FDA panel recommends approval for Factive in respiratory tract infections

Argatroban meets primary endpoints in ARGIS-I study

Lercanidipine 20 mg approved in Europe

Dryvax side effects reduced by prior immunization with NYVAC or MVA

NIH licensing opportunity: gp64 pseudotyped vectors and uses thereof

Discovery of potent and selective 5-HT7 receptor antagonists

A-349821 characterized as potent, selective, orally available H3 receptor antagonist

GVAX enhances antitumor immunity in certain patients with advanced NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...